Business Context and Reporting Period
Company: Hercules Technology Growth Capital, Inc. (HTGC)
Filing Type: Form 10-Q (Unaudited)
Period Ended: September 30, 2014
Business Overview: HTGC is an internally managed, non-diversified closed-end investment company regulated as a Business Development Company (BDC). It focuses on providing senior secured loans to venture capital-backed companies in technology-related markets, including biotechnology, life sciences, and energy technology. The company also operates two Small Business Investment Company (SBIC) subsidiaries, HT II and HT III.
Key Financial Metrics
| Metric | Three Months Ended Sep 30, 2014 | Nine Months Ended Sep 30, 2014 | Dec 31, 2013 (Balance Sheet) |
|---|---|---|---|
| Total Assets | $1,199.3 million | $1,199.3 million | $1,221.7 million |
| Total Investments (at Value) | $998.9 million | $998.9 million | $910.3 million |
| Cash and Cash Equivalents | $158.6 million | $158.6 million | $268.4 million |
| Total Liabilities | $543.1 million | $543.1 million | $571.7 million |
| Total Net Assets | $656.2 million | $656.2 million | $650.0 million |
| Net Asset Value (NAV) per Share | $10.22 | $10.22 | $10.51 |
| Net Investment Income | $19.0 million | $55.9 million | N/A |
| Net Realized Gain on Investments | $5.7 million | $13.0 million | N/A |
| Net Unrealized Appreciation (Depreciation) | $(9.5) million | $(18.3) million | N/A |
| Net Increase in Net Assets from Operations | $15.2 million | $50.6 million | N/A |
| Dividends Declared per Share | $0.31 | $0.93 | N/A |
Material Changes vs. Prior Period
- Portfolio Growth: Total investment portfolio value increased to $998.9 million from $910.3 million at year-end 2013, driven by new fundings of approximately $408.3 million in debt and $5.1 million in equity during the nine-month period.
- Unrealized Depreciation: The company recorded a net unrealized depreciation of $18.3 million for the nine months ended September 30, 2014, compared to net unrealized appreciation of $9.0 million in the same period in 2013. This was primarily due to collateral-based impairments on nine portfolio companies and the reversal of prior unrealized appreciation upon the exercise of warrants (specifically Box, Inc. and Neuralstem, Inc.).
- Debt Structure Changes:
- Convertible Senior Notes: Approximately $34.1 million of Convertible Senior Notes were converted to common stock during the quarter, resulting in a $1.0 million loss on debt extinguishment.
- 2024 Notes: Issued $103.0 million in 6.25% Senior Notes due 2024 in July 2014.
- SBA Debentures: Repaid $34.8 million of SBA debentures in March 2014.
- Asset-Backed Notes: Outstanding balance decreased from $89.6 million to $28.0 million due to amortization.
- Operating Expenses: Total operating expenses decreased to $49.9 million for the nine months ended September 30, 2014, from $52.3 million in the prior year period, largely due to lower variable compensation accruals.
Guidance, Outlook, and Risks
- Liquidity: As of September 30, 2014, the company had $308.6 million in available liquidity, including $158.6 million in cash and $150.0 million in available borrowing capacity under the Wells and Union Bank facilities. The company also has $112.5 million in restricted cash related to SBIC operations.
- Dividend Policy: The Board declared a quarterly dividend of $0.31 per share, payable November 24, 2014. The company aims to distribute approximately 90-100% of its taxable income. Approximately $3.8 million of spillover earnings from 2013 is expected to be distributed in 2014.
- Portfolio Grading: The weighted average investment grading of the debt portfolio improved to 2.07 from 2.20 at year-end 2013. However, three debt investments were on non-accrual status with a fair value of $6.5 million.
- Risks and Contingencies:
- Valuation Risk: Approximately 83.3% of total assets are Level 3 investments valued by the Board of Directors, subject to significant judgment and potential volatility.
- Concentration Risk: The top five industries (Drug Discovery, Medical Devices, Software, Internet Services, Energy Technology) comprised 68.9% of the portfolio.
- Regulatory Compliance: The company must maintain asset coverage ratios under the 1940 Act. As of September 30, 2014, the asset coverage ratio was 292.2% (excluding SBA debentures) and 223.4% (including SBA debentures).
Key Facts for Investor Verification
- Unrealized Loss Drivers: Verify the specific portfolio companies responsible for the $12.6 million in collateral-based impairments on debt investments and the $8.3 million in warrant depreciation related to Box, Inc.
- Debt Conversion Impact: Confirm the dilution impact of the $34.1 million Convertible Senior Notes conversion (settled with cash and ~924,000 shares) and the subsequent $23.1 million conversion reported in subsequent events.
- Non-Accrual Status: Review the status of the three debt investments on non-accrual (cost $21.7 million, fair value $6.5 million) and the likelihood of recovery.
- Unfunded Commitments: Note the $242.5 million in unfunded contractual commitments, of which $138.5 million is milestone-dependent, representing potential future cash outflows.
- Subsequent Events: Verify the pricing of the new $129.3 million 2021 Asset-Backed Notes announced in November 2014 and the impact of recent M&A transactions (e.g., VaultLogix, Location Labs, SiTime) on portfolio valuations.